II 

115TH CONGRESS 

1ST SESSION S. 2004 

To increase funding for the State response to the opioid misuse crisis and 

to provide funding for research on addiction and pain related to the 

substance misuse crisis. 

IN THE SENATE OF THE UNITED STATES 

OCTOBER 25, 2017 

Mr. CASEY (for himself, Mr. MARKEY, Ms. HASSAN, Mr. HEINRICH, Mrs. 

SHAHEEN, Mr. KAINE, Mrs. FEINSTEIN, Ms. KLOBUCHAR, Mr. 

FRANKEN, Mr. KING, Ms. BALDWIN, Ms. WARREN, Mr. BROWN, Mr. 

MENENDEZ, Ms. HARRIS, Mr. UDALL, and Mr. NELSON) introduced the 

following bill; which was read twice and referred to the Committee on 

Health, Education, Labor, and Pensions 

A BILL 

To increase funding for the State response to the opioid 

misuse crisis and to provide funding for research on 

addiction and pain related to the substance misuse crisis. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Combating the Opioid 

5 Epidemic Act’’. 


lotter on DSKBCFDHB2PROD with BILLS
2 

•S 2004 IS

1 SEC. 2. ADDITIONAL FUNDING FOR THE STATE RESPONSE. 

2 (a) FUNDING.—Section 1003 of the 21st Century 

3 Cures Act (42 U.S.C. 290ee–3 note) is amended— 

4 (1) in subsection (a), by striking ‘‘under sub5 section (b)’’ and inserting ‘‘under subsection (b)(3) 

6 and the appropriations under subsection (b)(4)’’; 

7 (2) in subsection (b), by adding at the end the 

8 following: 

9 ‘‘(4) ADDITIONAL APPROPRIATIONS.—In addi10 tion to the amounts transferred to the Account 

11 under paragraph (2)(A), there are authorized to be 

12 appropriated, and there are appropriated, to the 

13 Secretary, out of monies in the Treasury not other14 wise obligated, $4,474,800,000 for each of fiscal 

15 years 2018 through 2027, to carry out the grant 

16 program described in subsection (c). Such funds 

17 shall remain available until expended.’’; and 

18 (3) by striking subsection (f). 

19 (b) ACTIVITIES.—Section 1003(c)(1) of the 21st Cen20 tury Cures Act (42 U.S.C. 290ee–3 note) is amended— 

21 (1) by redesignating subparagraph (E) as sub22 paragraph (G); and 

23 (2) by inserting after subparagraph (D) the fol24 lowing: 

25 ‘‘(E) Detection, surveillance, and treat26 ment of co-occurring infections associated with 


lotter on DSKBCFDHB2PROD with BILLS
3 

•S 2004 IS

1 the opioid epidemic, including hepatitis C and 

2 HIV. 

3 ‘‘(F) Surveillance, data collection, and 

4 timely and consistent reporting on the number 

5 of opioid overdose deaths, including the inci6 dence and prevalence of co-occurring infections 

7 and toxicology reporting on the number of 

8 deaths where fentanyl or other illicit opioid 

9 analogs were detected.’’. 

10 SEC. 3. GRANTS FOR RESEARCH ON ADDICTION AND PAIN. 

11 (a) IN GENERAL.—The Secretary of Health and 

12 Human Services (referred to in this section as the ‘‘Sec13 retary’’) shall use any funds appropriated under sub14 section (b) to award grants for the purpose of conducting 

15 research on addiction and pain related to substance mis16 use. The Secretary, acting through the Director of the Na17 tional Institutes of Health, shall determine the amount of 

18 each grant awarded under this section. 

19 (b) APPROPRIATIONS.—There are authorized to be 

20 appropriated, and there are appropriated, to the Sec21 retary, out of monies in the Treasury not otherwise obli22 gated, $50,400,000 for each of fiscal years 2018 through 

23 2022, to carry out the grant program described in subVerDate Sep 11 2014 00:26 Oct 27, 2017 Jkt 079200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\S2004.IS S2004

lotter on DSKBCFDHB2PROD with BILLS
4 

•S 2004 IS

1 section (a). Such funds shall remain available until ex2 pended. 

Æ 


lotter on DSKBCFDHB2PROD with BILLS